Rhythm Pharmaceuticals, Inc. (RYTM)
99.78
-3.38
(-3.28%)
USD |
NASDAQ |
Feb 20, 16:00
98.09
-1.69
(-1.69%)
After-Hours: 20:00
Rhythm Pharmaceuticals Research and Development Expense (Quarterly) : 45.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Geron Corp. | 21.07M |
| Sarepta Therapeutics, Inc. | 218.89M |